Page last updated: 2024-08-05 10:49:43
hydroquinones
Benzenediols that have the hydroxy substituents in the 1- and 4-positions.
ChEBI ID: 24646
Members (11)
| Member | Definition | Role |
|---|---|---|
| 2-(s-glutathionyl)hydroquinone | A glutathione conjugate in which the thiol hydrogen of glutathione has been replaced by a 2,5-dihydroxyphenyl group. | 2-(glutathion-S-yl)-1,4-hydroquinone |
| 2-methyl-1,4-hydroquinone | A member of the class of hydroquinones that is hydroquinone in which one of the benzene hydrogens has been replaced by a methyl group. | toluquinol |
| 2-tert-butylhydroquinone | A member of the class of hydroquinones in which one of the ring hydrogens of hydroquinone is replaced by a tert-butyl group. | 2-tert-butylhydroquinone |
| 2,3,5-trimethylquinol | A member of the class of hydroquinones that is hydroquinone substituted by methyl groups at positions 2, 3 and 5. | 2,3,5-trimethylhydroquinone |
| 2,5-di-tert-butylhydroquinone | A member of the class of hydroquinones that is benzene-1,4-diol substituted by tert-butyl groups at position 2 and 5. | 2,5-di-tert-butylbenzene-1,4-diol |
| cytotrienin a | A 21-membered macrocyclic lactam which contains three conjugated double bonds as part of the ring system. It acts as an apoptosis inducer in human leukemia HL-60 cells and is isolated from Streptomyces sp. | cytotrienin A |
| duroquinol | A member of the class of hydroquinones that is benzene-1,4-diol carrying four methyl groups at positions 2, 3, 5 and 6. | durohydroquinone |
| flavoglaucin | Flavoglaucin | |
| homogentisic acid | A dihydroxyphenylacetic acid having the two hydroxy substituents at the 2- and 5-positions. | homogentisic acid |
| hydroquinone | A benzenediol comprising benzene core carrying two hydroxy substituents para to each other. | hydroquinone |
| methyl 2,5-dihydroxycinnamate | A cinnamate ester that is the methyl ester of 2,5-dihydroxycinnamic acid. | 2,5-dihydroxycinnamic acid methyl ester |
Research
Studies (3,133)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 399 (12.74) | 18.7374 |
| 1990's | 664 (21.19) | 18.2507 |
| 2000's | 789 (25.18) | 29.6817 |
| 2010's | 981 (31.31) | 24.3611 |
| 2020's | 300 (9.58) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 118 (3.56%) | 5.53% |
| Reviews | 157 (4.73%) | 6.00% |
| Case Studies | 171 (5.16%) | 4.05% |
| Observational | 1 (0.03%) | 0.25% |
| Other | 2,870 (86.52%) | 84.16% |